Archive - February 2021
Multiple rolling reviews kick-off for Novavax’s COVID-19 vaccine
NICE launches public consultation for process review
Pfizer aims for $15bn in 2021 COVID-19 vaccine sales
Full impact of COVID-19 pandemic on cancer treatment unknown, according to GlobalData
GSK and CureVac look to develop next-generation mRNA COVID-19 vaccines
Breast Cancer Patients Who Tell Surgeons, “Go Flat,” Often Are Ignored
UK launches world-first COVID-19 study evaluating a mixed-vaccine regimen
Exonate launches diabetic macular oedema trial